Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
ipo
2
×
2025
ad-comm
affimed
akcea therapeutics
allogene therapeutics
amicus therapeutics
approval
apremilast
base editing
bio
biogen
biome
biotech
blueprint medicineas
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
briefing docs
cannabis
car-t
celgene
cervical cancer
clinical study
clinical trial
commissioner
crispr
crispr therapeutics
cybersecurity
democrats
detection
detroit blog main
detroit top stories
digital health
diversity
donald trump
endpoints
fail
failure
What
ipo
million
shares
2
×
allogene
apiece
based
bio
british
cancer
cannabis
closing
columbia
company
crispr
diversity
governments
high
hot
immunotherapy
investors
juno
marijuana
medical
nasdaq
nearly
new
old
patients
pharmacies
priced
products
public
remains
researchers
roundup
saw
sells
shareholders
snapped
soar
Language
Current search:
shares
×
ipo
×
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@techcrunch.com
5 years ago
Public shareholders got high today on Tilray, the first marijuana company to IPO on Nasdaq
